Sex influence on cancer immunotherapy efficacy and safety in advanced non-small cell lung cancer (NSCLC): A Canadian institution real-world experience

被引：0
|
作者：
Cohen, Sara Frida
Cruiziat, Diane
Naimer, Jeremy
Cohen, Victor
Kasymjanova, Goulnar
Spatz, Alan
Agulnik, Jason Scott
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] McGill Univ, Lady Davis Inst, Jewish Gen Hosp, Peter Brojde Lung Canc Ctr, Montreal, PQ, Canada
[3] McGill Univ, Lady Davis Inst, Jewish Gen Hosp, Montreal, PQ, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20618
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-World Efficacy and Safety of Anlotinib with and without Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Xiong, Q.
    Qin, B.
    Xin, L.
    Yang, B.
    Hu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S676 - S676
  • [2] Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Xiong, Qi
    Qin, Boyu
    Xin, Lingli
    Yang, Bo
    Song, Qi
    Wang, Yu
    Zhang, Sujie
    Hu, Yi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
    Fen Wang
    Feng Jin
    Boran Cheng
    Yue Zhang
    Qing Zhou
    Shubin Wang
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1721 - 1735
  • [4] The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
    Wang, Fen
    Jin, Feng
    Cheng, Boran
    Zhang, Yue
    Zhou, Qing
    Wang, Shubin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (07) : 1721 - 1735
  • [5] The Real-World Efficacy and Safety of Anlotinib Treatment for Advanced Non-Small Cell Lung Cancer
    Wang, F.
    Jin, F.
    Wang, S.
    Zhu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S673 - S673
  • [6] Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Zhang, Kun
    Ma, Xiya
    Gao, Hongjun
    Wang, Hong
    Qin, Haifeng
    Yang, Shaoxing
    Liu, Xiaoqing
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3409 - 3417
  • [7] A Real-World Study: Efficacy and Safety of Anlotinib for Advanced Non-Small Cell Lung Cancer
    Wang, J.
    Yi, T.
    Dong, Y.
    Ran, R.
    Cao, F.
    Li, Y.
    Luo, Z.
    Xu, Y.
    Fu, Y.
    Kuang, L.
    Chen, G.
    Qu, G.
    Yin, Y.
    Li, J.
    Xu, X.
    Chen, Y.
    Song, Q.
    Chu, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1071 - S1071
  • [8] Real-World Experience of Consolidation Durvalumab for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
    Barbaro, A.
    Mienko, F.
    Deng, L.
    Ohri, N.
    Halmos, B.
    Perez-Soler, R.
    Gucalp, R.
    Bodner, W.
    Cheng, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S906 - S907
  • [9] Real-world experience of treatment with afatinib in advanced non-small cell lung cancer (NSCLC) in Vietnam
    Dong, H.
    Tuan, K. Nguyen
    Bui, T. T. P.
    Dong, H.
    ANNALS OF ONCOLOGY, 2022, 33 : S1590 - S1590
  • [10] Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: a real-world observation study
    Ma, Ke
    Guo, Qianqian
    Li, Xingya
    BMC PULMONARY MEDICINE, 2023, 23 (01)
12345